Sarah Warzywoda, James A. Fowler, Penny Wood, Fiona Bisshop, Darren Russell, Hemming Luu, Melissa Kelly, Victoria Featherstone, Judith A. Dean
{"title":"剂量可以降到多低？为要求使用女性化荷尔蒙的变性者和性别多元化者调整醋酸环丙孕酮的最低有效剂量","authors":"Sarah Warzywoda, James A. Fowler, Penny Wood, Fiona Bisshop, Darren Russell, Hemming Luu, Melissa Kelly, Victoria Featherstone, Judith A. Dean","doi":"10.1080/26895269.2024.2317395","DOIUrl":null,"url":null,"abstract":"Background: Administration of cyproterone acetate (CPA), to reduce the production and effects of testosterone, is often part of clinical regimens for trans individuals seeking feminization. Due to ...","PeriodicalId":48480,"journal":{"name":"International Journal of Transgender Health","volume":"23 1","pages":""},"PeriodicalIF":10.5000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones\",\"authors\":\"Sarah Warzywoda, James A. Fowler, Penny Wood, Fiona Bisshop, Darren Russell, Hemming Luu, Melissa Kelly, Victoria Featherstone, Judith A. Dean\",\"doi\":\"10.1080/26895269.2024.2317395\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Administration of cyproterone acetate (CPA), to reduce the production and effects of testosterone, is often part of clinical regimens for trans individuals seeking feminization. Due to ...\",\"PeriodicalId\":48480,\"journal\":{\"name\":\"International Journal of Transgender Health\",\"volume\":\"23 1\",\"pages\":\"\"},\"PeriodicalIF\":10.5000,\"publicationDate\":\"2024-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Transgender Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/26895269.2024.2317395\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Transgender Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/26895269.2024.2317395","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones
Background: Administration of cyproterone acetate (CPA), to reduce the production and effects of testosterone, is often part of clinical regimens for trans individuals seeking feminization. Due to ...
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
